ERBB2 and breast carcinoma: Next, we determined the correlation between DEPTOR expression and patient survival using breast tissue microarrays, which consisted of 138 breast carcinomas, including 53 luminal A, 48 luminal B, 15 HER2 over-expression, and 22 basal-like.